Questions & Answers
Q1
Direct Answer
▸
Context
The UK is a world leader in tackling the global challenge of antimicrobial resistance, having invested £615 million since 2014.
David Davis questions whether the Department's level of work and research regarding novel approaches like genomics, combination drugs, and new vaccinations matches the threat posed by AMR, given estimates that up to 10 million people could die annually from it by 2050.
Matthew Hancock acknowledges the threat posed by AMR, stating that microbial illness and disease are as significant a risk as viral diseases. He confirms ongoing investments and indicates more to come.
▸
Assessment & feedback
Response accuracy